CEO Dan Mandell joined Kevin Folta on the Talking Biotech Podcast for an in-depth, technical conversation on the potential of protein therapeutics.
In this episode Dan and Kevin discuss how expanding the amino acid alphabet with GRObio’s GRO platform enables precise regulation of the immune system for patients suffering from autoimmune disease including myasthenia gravis.
